Tomorrow Capital invests in kidney start-up VitusCare
NEW DELHI: Tomorrow Capital, a $100 million VC fund, is investing $2.7 million in VitusCare as part of its Series A funding round. VitusCare, a kidney care start-up founded in 2017, has emerged as a player of quality dialysis care, particularly in regions where access to such services is limited, a company statement said. The fresh capital injection will empower VitusCare to aggressively expand its operations, with a targeted focus on deeper penetration into the hinterland. In addition, the funding round saw participation from existing investor 1Crowd, alongside support from 3i Partners and a consortium of angel investors, totalling approximately $5 million in funding across all the funding rounds. Tomorrow Capital, part of Lodha Ventures, has investments in healthcare, fitness and educat...